TTP
Robotic manufacturing automation for cell therapy developers and manufacturers
Highlights
- Young companyFounded 2022
- Hiring45 open roles
About TTP
Cellular Origins develops Constellation, an automated platform for manufacturing autologous and allogeneic cell therapies. It combines modular workstations, mobile robots, sterile fluid transfer and software that orchestrates workflows and records production activity.
The platform is offered as a capital investment for deployment in new or existing facilities. Cellular Origins also works with selected contract development and manufacturing partners for clients seeking outsourced manufacturing.
Founded in 2022 and headquartered in Melbourn, UK, the business originated within TTP and launched as a spin-out in 2023. It raised a Series A round in 2025 and has US operations supporting customers across North America.
Product: Constellation is a robotic cell therapy manufacturing platform integrating bioprocessing instruments, sterile fluid transfer and workflow software.
Jobs at TTP (45)
TTP is hiring for 45 roles, mostly in engineering, based in Melbourn and Cambridge.
Lead Electronic Engineer Consultant
Young companyFacilities Manager
Young companyCommercial Consultant - Advanced Surgical Systems
Young companyElectronic Engineering Consultant
Young companyRobotics Engineer
Young companyAdministrator Apprentice
Young companyQuality Manager
Young companySenior Software Engineer - Robotics
Young company
Companies hiring like TTP
Leadership
- Edwin Stone · Chief Executive OfficerSource: company website
- Dan Strange · Chief Technology OfficerSource: company website
- Peter Crossley · Chief Operating OfficerSource: company website
- Jason Jones · Head of Global Business DevelopmentSource: company website
More biotech & pharma companies
Veramed
Clinical trial biometrics services (data management, biostatistics, programming) for pharma and biotech sponsorsNew on EvolcVerdiva Bio
Develops once-weekly peptide medicines for obesity and cardiometabolic disease, with a lead drug in Phase 2 trialsYoung companyNew on EvolcWaymade PLC
Specialty pharmaceutical company developing, licensing and commercialising generic and niche medicines for patients worldwideNew on EvolcWellcome
Charitable foundation funding biomedical research on health challenges and running a free museum and library in LondonNew on EvolcRemote-friendlySalary transparentXap Therapeutics
Cell-based multi-modal therapies for cancer and autoimmune disease, built on a modified immune-cell delivery platformNew on Evolc4C Biomed
Pre-clinical immuno-oncology company finding immune targets and developing antibody drugs for cancer treatmentNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
CRM & customer data
- HubSpotHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.